会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Tropoelastin-based protoelastin biomaterials
    • 基于原始弹力蛋白的原弹性蛋白生物材料
    • US07700126B2
    • 2010-04-20
    • US11864006
    • 2007-09-28
    • Martin Kean Chong NgAnthony Steven WeissSteven Garry Wise
    • Martin Kean Chong NgAnthony Steven WeissSteven Garry Wise
    • A61F2/00
    • A61K38/39A61L27/227A61L27/26A61L27/34A61L31/047A61L31/10
    • Biocompatible materials suitable for use in vascular applications have been engineered, combining human recombinant tropoelastin with other synthetic or natural biomaterials to form protoelastin. The materials can be in the form of elastin films on metal, bone, ceramic or polymer substrates, laminates of alternating polymer and elastin, blends of polymer and elastin, or elastin crosslinked with or tethered to polymer. The flexibility in engineering and design makes protoelastin biomaterials suited not only to the production of conduits but any number of other vascular applications that require blood contacting surfaces. Tropoelastin and the subsequently engineered biomaterial protoelastin provide the opportunity to satisfy a large unmet need for a biocompatible material adaptable enough to meet a range of diverse vascular uses. These are mechanically stable, elastic, strong and biocompatible (i.e., not thrombogenic and promoting adhesion of cells, especially human endothelial cells.
    • 已经设计了适用于血管应用的生物相容性材料,将人重组托拉斯特蛋白与其他合成或天然生物材料组合以形成原胶原蛋白。 材料可以是金属,骨,陶瓷或聚合物基底上的弹性蛋白膜,交替聚合物和弹性蛋白的叠层,聚合物和弹性蛋白的共混物,或与聚合物交联或连接的弹性蛋白。 工程和设计的灵活性使得原胶原生物材料不仅适用于导管的生产,而且也适用于需要接触血液的表面的任何数量的其他血管应用。 托罗弹性蛋白和随后改良的生物材料原弹性蛋白提供了满足大量未满足的生物相容性材料需求的机会,其适应性足以满足多种血管用途的范围。 这些是机械稳定的,弹性的,强的和生物相容的(即,不是血栓形成和促进细胞,特别是人内皮细胞的粘附。
    • 4. 发明授权
    • Synthetic polynucleotides
    • 合成多核苷酸
    • US06277622B1
    • 2001-08-21
    • US09242095
    • 1999-02-08
    • Anthony Steven Weiss
    • Anthony Steven Weiss
    • C12N120
    • C12N9/0022
    • This invention relates to synthetic polynucleotides which encode lysyl oxidase, lysyl oxidase like molecules or variants of these species. The synthetic polynucleotides of the invention permit the expression of functional lysyl oxidase, lysyl oxidase like molecules or variants of these species, typically in good yield. The invention also relates to recombinant DNA molecules containing these, synthetic polynucleotides, to cells containing them and to uses of the expression products.
    • 本发明涉及编码赖氨酰氧化酶,赖氨酰氧化酶样分子或这些物种的变体的合成多核苷酸。 本发明的合成多核苷酸允许功能性赖氨酰氧化酶,赖氨酰氧化酶如分子或这些物种的变体的表达,通常以良好的产率。 本发明还涉及含有这些,合成多核苷酸,含有它们的细胞和表达产物的用途的重组DNA分子。
    • 6. 发明授权
    • Protease susceptibility II
    • 蛋白酶敏感性II
    • US07229788B1
    • 2007-06-12
    • US09743818
    • 1999-07-19
    • Anthony Steven Weiss
    • Anthony Steven Weiss
    • C12N15/00C07K1/00C07K14/00
    • C07K7/02A61K38/00C07K14/78
    • The present invention relates to: manipulation of the amino acid sequence of tropoelastin, particularly human tropoelastin, to modify its protease susceptibility; to tropoelastin derivatives having modified protease susceptibility; to peptidomimetic molecules which contain amino acid sequences which correspond to or incorporate the protease susceptible sequences of tropoelastin; and to uses of the tropoelastin derivatives and peptidomimetic molecules.The invention also relates to nucleic acid molecules and genetic constructs encoding the amino acid sequences of the derivatives and peptidomimetic molecules of the invention.
    • 本发明涉及:对托普弹原蛋白(特别是人类托拉斯汀)的氨基酸序列的操纵,以改变其蛋白酶敏感性; 具有改变的蛋白酶敏感性的托普拉斯汀衍生物; 含有对应于或掺入蛋白酶敏感序列的氨基酸序列的拟肽分子; 并使用托普弹力素衍生物和拟肽分子。 本发明还涉及编码本发明的衍生物和拟肽分子的氨基酸序列的核酸分子和遗传构建体。